Clinical Trials Directory

Trials / Completed

CompletedNCT00227084

Effect of Arista Powder on Bleeding in Reductive Mammary Surgery

Effect of Arista AH-Haemostatic Powder in Plastic Surgery. A Prospective, Consecutive Randomized Study in 30 Women Undergoing Reduction of Both Mamma

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
30 (planned)
Sponsor
University of Oslo · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

To evaluate whether Arista AH which contains microporous polysaccharides used as a powder applied to the wound area during mammary surgery reduces the amount of bleeding and the duration of surgery. Both mammae are operated on in the same procedure, and one side without Arista serves as control side

Detailed description

During the operation,before the first incision a randomization envelope is opened. Always starts on the same side, with or without Arista according to the envelope. After surgery, vacuum drains are placed and the amount of drained material and hgb content is measured 24 hours later by nursing staff blinded to what side had Arista.Patients scores postoperative pain with VAS score bilaterally. Three months postoperatively the patients are checked by a physician blinded for what side had Arista

Conditions

Interventions

TypeNameDescription
DRUGArista AH hemostasis powder

Timeline

Start date
2005-09-01
Completion
2006-10-01
First posted
2005-09-27
Last updated
2007-08-27

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT00227084. Inclusion in this directory is not an endorsement.

Effect of Arista Powder on Bleeding in Reductive Mammary Surgery (NCT00227084) · Clinical Trials Directory